NORSPAN

This brand name is authorized in Austria, Australia, Germany, Ecuador, Estonia, Finland, Hong Kong, Japan, Lithuania, New Zealand

Active ingredients

The drug NORSPAN contains one active pharmaceutical ingredient (API):

1 Buprenorphine UNII 40D3SCR4GZ - BUPRENORPHINE

Buprenorphine is an opioid partial agonist/antagonist which attaches itself to the μ (mu) and κ (kappa) receptors of the brain. Its activity in opioid maintenance treatment is attributed to its slowly reversible link with the μ receptors which, over a prolonged period, minimises the need of illicit opioids for patients with opioid dependence. Read about Buprenorphine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
NORSPAN Patch	Medicines and Medical Devices Safety Authority (NZ)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N02AE01	Buprenorphine	N Nervous system → N02 Analgesics → N02A Opioids → N02AE Oripavine derivatives
Discover more medicines within N02AE01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 10746N, 10755C, 10756D, 10770W, 10948F, 10949G, 10953L, 10957Q, 10959T, 10964C, 10970J, 8865N, 8866P, 8867Q
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 00683602, 00683619, 00683660, 00684317, 00684346, 00684352, 03323258, 03323264, 03323287, 10005843, 10005866, 10005872, 10179684, 10179690, 10179709, 10179715, 10179721, 10179738, 10179744, 10179750, 10179767, 10226099, 10226107, 10226113, 10226136, 10226142, 10226159, 10226165, 10226171, 10226188, 11525467, 11525473, 11525496, 11525504, 11525510, 11525527, 16003555, 16003561, 17532994, 17533002, 17533019, 17533025, 17533031
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 1648-MEE-0116, 1788-MEE-0216, 2244-MEE-0616
Country: EE	Ravimiamet	Identifier(s): 1305885, 1305908, 1305919, 1305920, 1305931, 1305942, 1305953, 1305964, 1305975, 1305986, 1305997, 1306000, 1306011, 1306022, 1306033, 1306044, 1306055, 1306066, 1306077, 1306088, 1306099, 1306101, 1306112, 1306123
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 068046, 068112, 149386, 149397, 149408, 183264, 433624, 456128
Country: HK	Department of Health Drug Office	Identifier(s): 61495, 61496, 61497
Country: JP	医薬品医療機器総合機構	Identifier(s): 1149704S1020, 1149704S2027, 1149704S3023
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1026205, 1026206, 1026207, 1033071, 1033072, 1033073, 1033074, 1033075, 1033076, 1033077, 1033078, 1033079, 1033080, 1033081, 1033082, 1033083, 1033084, 1033085, 1033086, 1033087, 1033088, 1033089, 1033090, 1033091
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 12436, 12437, 12438